EZZ Life Science Holdings Ltd. (AU:EZZ) has released an update.
Don’t Miss TipRanks’ Half Year Sale
- Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
EZZ Life Science Holdings Ltd. reported a stellar financial year, with a remarkable 78.9% revenue growth, fueled by strategic product innovation and expansion into international markets. The company’s EBITDA more than doubled, reaching $10.4 million, while maintaining strong gross margins above 75%. These achievements, supported by a robust cash position and no significant debt, poise EZZ for continued growth and shareholder value.
For further insights into AU:EZZ stock, check out TipRanks’ Stock Analysis page.